Company Filing History:
Years Active: 1976-1977
Title: The Innovative Contributions of David Lord Pain
Introduction
David Lord Pain is a noteworthy inventor based in Upminster, GB, recognized for his significant contributions to the field of pharmacology. With a portfolio of four patents, he has focused on innovations that address respiratory disorders, particularly allergic bronchial asthma. His work embodies a blend of scientific expertise and inventive flair, which has propelled advancements in medical treatments.
Latest Patents
Among his most recent patents, Lord Pain's work on Azapurinones stands out. This invention details unique 8-Azapurin-6-ones that are substituted in the 2-position by a phenyl group, which itself includes a meta-positioned sulfamoyl substituent, alongside para-positioned hydroxy, alkoxy, or alkylthio substituents. These compounds exhibit pharmacological properties that can be beneficial in treating allergic respiratory disorders. Another noteworthy patent in this area involves novel derivatives of 8-azapurin-6-ones, again substituted to enhance their utility in addressing respiratory ailments linked to the interaction of tissue-fixed antibodies with specific antigens.
Career Highlights
David Lord Pain is currently associated with May & Baker, Ltd., a company that focuses on developing pharmaceutical products. His role there has allowed him to channel his inventive prowess into real-world applications that aim to improve patient outcomes in the respiratory health sector.
Collaborations
Throughout his career, Pain has collaborated with esteemed colleagues, including Barbara Joyce Broughton and Bryan John Large. These partnerships reflect the collaborative nature of innovation in the pharmaceutical industry, bringing together diverse expert perspectives to advance healthcare solutions.
Conclusion
David Lord Pain's inventive journey underscores the vital role of innovation in the biomedical field. His latest patents in the area of respiratory treatment serve as a testament to his commitment to improving health outcomes for patients affected by allergic disorders. With his continued work at May & Baker, Ltd., Pain is poised to make further contributions that can positively impact medical science and patient care.